Next Generation Sequencing (NGS)-based BRCA tumour tissue testing poses several challenges. As a first step of its implementation within a regional health service network, an in-house validation study was compared with published recommendations.
Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations
Rivera, Daniela;Paudice, Michele;Anselmi, Giorgia;Vellone, Valerio Gaetano;Varesco, Liliana
2020-01-01
Abstract
Next Generation Sequencing (NGS)-based BRCA tumour tissue testing poses several challenges. As a first step of its implementation within a regional health service network, an in-house validation study was compared with published recommendations.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jclinpath-2020-206840.full.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
353.8 kB
Formato
Adobe PDF
|
353.8 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
